EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ceragenin-mediated disruption of Pseudomonas aeruginosa biofilms

Urszula Wnorowska, Dawid Łysik, Ewelina Piktel, Magdalena Zakrzewska, Sławomir Okła, Agata Lesiak, Jakub Spałek, Joanna Mystkowska, Paul B Savage, Paul Janmey, Krzysztof Fiedoruk, Robert Bucki iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0298112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Urszula Wnorowska und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, Poland. Hauptthemen laut MEDLINE: Anti-Infective Agents, Cystic Fibrosis, Pseudomonas Infections, Steroids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Uniwersytet Medyczny w Bialymstoku, Medical University of Białystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microbial biofilms, as a hallmark of cystic fibrosis (CF) lung disease and other chronic infections, remain a desirable target for antimicrobial therapy. These biopolymer-based viscoelastic structures protect pathogenic organisms from immune responses and antibiotics. Consequently, treatments directed at disrupting biofilms represent a promising strategy for combating biofilm-associated infections. In CF patients, the viscoelasticity of biofilms is determined mainly by their polymicrobial nature and species-specific traits, such as Pseudomonas aeruginosa filamentous (Pf) bacteriophages. Therefore, we examined the impact of microbicidal ceragenins (CSAs) supported by mucolytic agents–DNase I and poly-aspartic acid (pASP), on the viability and viscoelasticity of mono- and bispecies biofilms formed by Pf-positive and Pf-negative P . aeruginosa strains co-cultured with Staphylococcus aureus or Candida albicans .

Methods

The in vitro antimicrobial activity of ceragenins against P . aeruginosa in mono- and dual-species cultures was assessed by determining minimum inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration (MBC/MFC). Inhibition of P . aeruginosa mono- and dual-species biofilms formation by ceragenins alone and in combination with DNase I or poly-aspartic acid (pASP) was estimated by the crystal violet assay. Additionally, the viability of the biofilms was measured by colony-forming unit (CFU) counting. Finally, the biofilms’ viscoelastic properties characterized by shear storage (G’) and loss moduli (G”), were analyzed with a rotational rheometer.

Results

Our results demonstrated that ceragenin CSA-13 inhibits biofilm formation and increases its fluidity regardless of the Pf-profile and species composition; however, the Pf-positive biofilms are characterized by elevated viscosity and elasticity parameters.

Conclusion

Due to its microbicidal and viscoelasticity-modifying properties, CSA-13 displays therapeutic potential in biofilm-associated infections, especially when combined with mucolytic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsCystic FibrosisPseudomonas InfectionsSteroidsHumansPseudomonas aeruginosaAspartic AcidExpectorantsAnti-Bacterial AgentsBiofilmsDeoxyribonuclease IMicrobial Sensitivity Tests

Substanzen

cerageninsAspartic AcidExpectorantsAnti-Bacterial AgentsAnti-Infective AgentsDeoxyribonuclease ISteroids

Autor:innen und Institutionen

  • Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, Poland.
  • Institute of Biomedical Engineering, Bialystok University of Technology, Bialystok, Poland.
  • Independent Laboratory of Nanomedicine, Medical University of Białystok, Białystok, Poland.
  • Institute of Medical Sciences, Collegium Medicum, Jan Kochanowski University of Kielce, Kielce, Poland.
  • Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah, United States of America.
  • Department of Physiology and Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

ORCID-Profile: Robert Bucki

Förderung

  • Narodowe Centrum Nauki
  • Uniwersytet Medyczny w Bialymstoku
  • Medical University of Białystok

Zitieren

APA

Wnorowska, U., Łysik, D., Piktel, E., Zakrzewska, M., Okła, S., Lesiak, A., Spałek, J., Mystkowska, J., Savage, P. B., Janmey, P., Fiedoruk, K., & Bucki, R. (2024). Ceragenin-mediated disruption of Pseudomonas aeruginosa biofilms. PLOS ONE. https://doi.org/10.1371/journal.pone.0298112

Vancouver

Wnorowska U, Łysik D, Piktel E, Zakrzewska M, Okła S, Lesiak A, et al. Ceragenin-mediated disruption of Pseudomonas aeruginosa biofilms. PLOS ONE. 2024. doi:10.1371/journal.pone.0298112

BibTeX
@article{Wnorowska2024,
  author = {Wnorowska, Urszula and Łysik, Dawid and Piktel, Ewelina and Zakrzewska, Magdalena and Okła, Sławomir and Lesiak, Agata and Spałek, Jakub and Mystkowska, Joanna and Savage, Paul B and Janmey, Paul and Fiedoruk, Krzysztof and Bucki, Robert},
  title = {Ceragenin-mediated disruption of Pseudomonas aeruginosa biofilms},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0298112}
}
Kostenlos starten →